NO20052751D0 - Oftalmisk preparat for behandling av okulaer hypertensjon. - Google Patents

Oftalmisk preparat for behandling av okulaer hypertensjon.

Info

Publication number
NO20052751D0
NO20052751D0 NO20052751A NO20052751A NO20052751D0 NO 20052751 D0 NO20052751 D0 NO 20052751D0 NO 20052751 A NO20052751 A NO 20052751A NO 20052751 A NO20052751 A NO 20052751A NO 20052751 D0 NO20052751 D0 NO 20052751D0
Authority
NO
Norway
Prior art keywords
treatment
ocular hypertension
ophthalmic preparation
ophthalmic
preparation
Prior art date
Application number
NO20052751A
Other languages
English (en)
Other versions
NO20052751L (no
Inventor
James B Doherty
Meng-Hsin Chen
Luping Liu
Swaminathan R Natarajan
Robert M Tynebor
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO20052751D0 publication Critical patent/NO20052751D0/no
Publication of NO20052751L publication Critical patent/NO20052751L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
    • C07F9/65038—Five-membered rings having the nitrogen atoms in the positions 1 and 2 condensed with carbocyclic rings or carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20052751A 2002-11-08 2005-06-07 Oftalmisk preparat for behandling av okulaer hypertensjon. NO20052751L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42480802P 2002-11-08 2002-11-08
US50009103P 2003-09-04 2003-09-04
PCT/US2003/035080 WO2004043933A1 (en) 2002-11-08 2003-11-04 Ophthalmic compositions for treating ocular hypertension

Publications (2)

Publication Number Publication Date
NO20052751D0 true NO20052751D0 (no) 2005-06-07
NO20052751L NO20052751L (no) 2005-06-07

Family

ID=32314559

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052751A NO20052751L (no) 2002-11-08 2005-06-07 Oftalmisk preparat for behandling av okulaer hypertensjon.

Country Status (22)

Country Link
US (2) US7196082B2 (no)
EP (1) EP1562909B1 (no)
JP (2) JP4456072B2 (no)
KR (1) KR20050072805A (no)
AR (1) AR041991A1 (no)
AU (2) AU2003286884A1 (no)
BR (1) BR0316040A (no)
CA (1) CA2505086C (no)
CL (1) CL2003002293A1 (no)
DO (1) DOP2003000747A (no)
EC (1) ECSP055781A (no)
HR (1) HRP20050409A2 (no)
IS (1) IS7822A (no)
MA (1) MA27497A1 (no)
MX (1) MXPA05004889A (no)
NO (1) NO20052751L (no)
NZ (1) NZ539593A (no)
PE (1) PE20040692A1 (no)
PL (1) PL377172A1 (no)
RU (1) RU2005117627A (no)
TW (1) TWI250873B (no)
WO (2) WO2004043932A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040028469A (ko) 2002-09-30 2004-04-03 엘지전자 주식회사 1 회 기록 가능한 광디스크의 디펙트 영역 관리방법
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
ATE425971T1 (de) * 2003-09-04 2009-04-15 Merck & Co Inc Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie
WO2006020003A2 (en) * 2004-07-20 2006-02-23 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
EP1647549A1 (en) * 2004-10-14 2006-04-19 Laboratoire Theramex Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents
KR101357465B1 (ko) * 2006-01-31 2014-02-03 어레이 바이오파마 인크. 키나제 억제제 및 그의 사용 방법
US20090062280A1 (en) * 2006-03-13 2009-03-05 Doherty James B Ophthalmic Compositions for Treating Ocular Hypertension
WO2007117465A2 (en) * 2006-03-31 2007-10-18 Abbott Laboratories Indazole compounds
WO2010051561A1 (en) * 2008-11-03 2010-05-06 Chemocentryx, Inc. Compounds for the treatment of osteoporosis and cancers
WO2012071369A2 (en) 2010-11-24 2012-05-31 The Trustees Of Columbia University In The City Of New York A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
WO2013166037A1 (en) 2012-05-01 2013-11-07 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of eye disorders
WO2014151959A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
ES2705247T3 (es) 2013-03-14 2019-03-22 Univ Columbia 4-fenilpiperidinas, su preparación y uso
US9944644B2 (en) 2013-03-14 2018-04-17 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles their preparation and use
ES2700541T3 (es) 2013-03-14 2019-02-18 Univ Columbia Octahidrociclopentapirroles, su preparación y uso
WO2015168286A1 (en) 2014-04-30 2015-11-05 The Trustees Of Columbia University In The City Of New York Substituted 4-phenylpiperidines, their preparaiton and use
CN104211638A (zh) * 2014-08-13 2014-12-17 李增 一种脂肪氨基取代的芸香碱类衍生物及其制备和作为抗阿尔兹海默症的药物中的应用
WO2017123826A1 (en) 2016-01-14 2017-07-20 Beth Israel Deaconess Medical Center, Inc. Mast-cell modulators and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534580A1 (fr) 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
US5151444B1 (en) 1987-09-18 1999-07-06 R Tech Ueno Ltd Ocular hypotensive agents
AU3693789A (en) 1988-05-10 1989-11-29 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) New ophthalmic preparation for treating glaucoma
WO1990002553A1 (en) 1988-09-06 1990-03-22 Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5296504A (en) 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5352708A (en) 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5922773A (en) 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
FR2701026B1 (fr) 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
JP3208210B2 (ja) * 1993-03-17 2001-09-10 旭化成株式会社 結晶性芳香族ポリカーボネートプレポリマーの製造方法及び芳香族ポリカーボネートの製造方法
EP0724443A4 (en) 1993-06-08 1997-09-10 Vide Pharmaceuticals METHOD AND PREPARATIONS FOR LOWERING THE EYE PRESSURE
US5510383A (en) 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5573758A (en) 1995-04-28 1996-11-12 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
AP2001002304A0 (en) * 1996-05-03 2001-12-31 Pfizer Substituted indazole derivatives and related compounds
US5925342A (en) 1996-11-13 1999-07-20 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
GB2321455A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
EP1114816A4 (en) 1998-09-14 2002-09-04 Ono Pharmaceutical Co SUBSTITUTED PHENYL-PROSTAGLANDIN E DERIVATIVES- $ g (V) AND MEDICINAL PRODUCTS CONTAINING THEM AS ACTIVE INGREDIENT
BR0016560A (pt) 1999-12-22 2002-09-10 Pfizer Prod Inc Agonistas seletivos do receptor ep4 no tratamento da osteoporose
US6545036B2 (en) 2000-01-18 2003-04-08 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
US6956036B1 (en) * 2000-03-17 2005-10-18 Alcon, Inc. 6-hydroxy-indazole derivatives for treating glaucoma
AU2001219180B2 (en) 2000-03-17 2005-04-07 Alcon, Inc. 5-hydroxy indazole derivatives for treating glaucoma
CA2402403A1 (en) 2000-03-17 2001-09-27 Alcon, Inc. 6-hydroxy-indazole derivatives for treating glaucoma
CN1366458A (zh) 2000-03-31 2002-08-28 东丽株式会社 毛发生长和毛发形成调节剂
AU2001290250A1 (en) 2000-09-21 2002-04-02 Ono Pharmaceutical Co. Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
ATE374182T1 (de) 2000-11-27 2007-10-15 Pfizer Prod Inc Selektive agonisten des ep4 rezeptors für die behandlung von osteoporose
FR2827861B1 (fr) 2001-07-27 2004-04-02 Aventis Pharma Sa Derives des indazoles ou des indoles, leur utilisation en medecine humaine et plus particulierement en cancerologie

Also Published As

Publication number Publication date
MA27497A1 (fr) 2005-08-01
WO2004043933A1 (en) 2004-05-27
CA2505086A1 (en) 2004-05-27
NZ539593A (en) 2006-12-22
IS7822A (is) 2005-04-25
AU2003286884A1 (en) 2004-06-03
JP5061293B2 (ja) 2012-10-31
CL2003002293A1 (es) 2005-01-14
JP2010006825A (ja) 2010-01-14
AU2003287506B2 (en) 2009-04-23
RU2005117627A (ru) 2006-01-20
HRP20050409A2 (en) 2006-02-28
TWI250873B (en) 2006-03-11
MXPA05004889A (es) 2005-07-22
BR0316040A (pt) 2005-09-13
AU2003287506A1 (en) 2004-06-03
NO20052751L (no) 2005-06-07
AR041991A1 (es) 2005-06-08
JP4456072B2 (ja) 2010-04-28
ECSP055781A (es) 2005-09-20
US7547720B2 (en) 2009-06-16
WO2004043932A1 (en) 2004-05-27
US20040097575A1 (en) 2004-05-20
PL377172A1 (pl) 2006-01-23
EP1562909A1 (en) 2005-08-17
US7196082B2 (en) 2007-03-27
CA2505086C (en) 2009-08-25
DOP2003000747A (es) 2004-05-31
JP2006508190A (ja) 2006-03-09
TW200501949A (en) 2005-01-16
AU2003287506B8 (en) 2009-05-28
US20070129418A1 (en) 2007-06-07
PE20040692A1 (es) 2004-10-08
EP1562909B1 (en) 2012-06-27
KR20050072805A (ko) 2005-07-12

Similar Documents

Publication Publication Date Title
NO20052751D0 (no) Oftalmisk preparat for behandling av okulaer hypertensjon.
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
DK1509121T3 (da) Okulærvisningsapparat til behandling af øjenlidelser
CY2015025I2 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
IL176393A0 (en) Patterned laser treatment of the retina
DK1656346T3 (da) 1,2,3,4-tetrasubstituerede indol til behandling af luftvejssygdomme
NO20053041D0 (no) Behandling av diabetes.
DK1575597T3 (da) Anvendelse af rimexolon til behandling af öjentörhed
AP2005003283A0 (en) Indole derivatives useful for the treatment os diseases
DK1474416T3 (da) Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser
DE60325209D1 (de) Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen
EP1646614A4 (en) OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCCULAR HYPERTONIA
NO20034590D0 (no) Fremgangsmåter for behandling av vaskul¶r sykdom
NO20043000L (no) Et preparat for behandling av nevrocerebrovaskulaere sykdommer
NO20055098D0 (no) Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser
FR2841767B1 (fr) Lentille intraoculaire accommodative
GB2402674B (en) Compositions and methods for the treatment of glaucoma or ocular hypertension
DK1411926T3 (da) Integrininhibitorer til behandling af öjensygdomme
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
EP1515722A4 (en) OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION
EP1664011A4 (en) OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCCULAR HYPERTONIA
EP1581503A4 (en) OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION
NO20052471D0 (no) Fremgangsmate for fremstilling av 3-metyltiopropanal.
EP1515721A4 (en) OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser